MeSH D007634 - keratitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| AbbVie | Dexamethasone | Ozurdex | 2023-01-09 | 2009-06-17 | $492 M | Q4/23-Q3/24 |
| Alcon Research | Loteprednol etabonate | Eysuvis | 2033-05-03 | 2020-10-26 |  |  |
| Loteprednol etabonate | Inveltys | 2033-05-03 | 2018-08-22 |  |  | |
| Dexamethasone | Maxidex |  | 1982-01-01 |  |  | |
| Dexamethasone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Dexamethasone |  | 1986-11-17 |  |  | |
| Dexamethasone, Neomycin | Neomycin Sulfate-dexamethasone |  | 1986-07-21 |  |  | |
| Allergan | Dexamethasone | Aeroseb-dex |  | 1982-01-01 |  |  |
| Dexamethasone | Dexamethasone |  | 1982-01-01 |  |  | |
| Alpharma | Dexamethasone | Dexamethasone |  | 1986-10-10 |  |  |
| Alvogen | Dexamethasone | Dexamethasone |  | 1983-04-28 |  |  |
| Amneal Pharmaceuticals | Dexamethasone | Dexamethasone |  | 2018-08-22 |  |  |
| Dexamethasone, Tobramycin | Tobramycin Dexamethasone |  | 2021-07-15 |  |  | |
| Apotex | Dexamethasone | Dexamethasone |  | 2023-08-23 |  |  |
| APP Pharmaceuticals | Dexamethasone | Dexamethasone |  | 1984-01-25 |  |  |
| Aspen Global | Dexamethasone | Hexadrol |  | 1982-01-01 |  |  |
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
100%2/2
Phase 3
38%13/34
Approved: 9Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use